Nikolaos StergiopoulosEducation
MTE, Managing the Technology Enterprise Program (2000), IMD, Lausanne
Ph.D. in Biomedical Engineering & Engineering Mechanics (1990) Iowa State University, Ames, Iowa.
MS in Biomedical Engineering (1987) Iowa State University, Ames, Iowa.
Diploma in Mechanical Engineering (1985) National Technical University of Athens.
Professional Activities
2002 - present: Professor and director of LHTC
2010 - present: Founder and director of Rheon Medical SA, Préverenges, Switzerland
2008 - present: Founder and director of Antlia S.A., PSE-C, EPFL campus, Switzerland
1998 - 2007: Founder and Scientific Director of EndoArt S.A., Lausanne, Switzerland
1996 - 2002: Assistant professor at the Biomedical Engineering Laboratory, Swiss Federal Institute of Technology, Lausanne, Switzerland.
1991 - 1996: Research Associate at Swiss Federal Institute of Technology - Lausanne
1990 - 1991: Lecturer, Iowa State University
Bruno HerbelinSince 10/09 - Scientist Laboratory of cognitive neuroscience Brain & Mind Institute, École Polytechnique Fédérale de Lausanne, Switzerland. 06/12 - 10/19 Deputy Director Center for Neuroprosthetics École Polytechnique Fédérale de Lausanne, Switzerland. 11/05 - 09/09 Assistant Professor Aalborg University Esbjerg Institute of Technology & Copenhagen Institute of Technology, Denmark. 07/01 - 09/05 Research assistant PhD student Virtual Reality Laboratory School of Computer and Communications, École Polytechnique Fédérale de Lausanne, Switzerland.
Jan Van HerleBorn in Antwerp, Belgium. In Switzerland since 1983. Became Swiss citizen in 2004 out of conviction of principles of democracy and bottom-up participation. No double nationality. Village Council Member for 2 five-year mandates in 2006-2016.
1987 : Chemist from Basel University (CH).
1988 : Post-graduate IT diploma from Basel Engineering School.
1989 : Industry internship ABB Baden (CH).
1990-1993 : PhD Thesis EPFL, on Solid Oxide Fuel Cell cathode reaction mechanisms.
1994-1995 : Japanese Postdoctoral Fellowship in Tsukuba, Japan, on ceramic powders.
1995-2000 : Researcher at EPFL, Dpt. Chemistry : project responsible in PPM2 (materials), FP4-BriteEuram, NEDO (Japan), Swiss Gas Union (CH, oxygen membranes).
1998-2000 : Masters in Energy Technology, EPFL.
2000 : Cofounder of HTceramix SA (EPFL spin-off), now based in Yverdon (14 employees). Taken over by SOLIDpower in 2007, now 250 employees with 70 MCHF raised.
2000 : 1st Assistant and lecturer at LENI (STI-IGM) : fuel cell group responsible, projects on biogas (Federal Energy Office), woodgas (CCEM), fuel cell stacking (CTI, FP6, FNS), ceramic separation membranes (COST, FNS), microtubes (STI Seed), stability/lifetime/reliability in fuel cells (Electricité de France, swisselectric research). Currently 4 Ph D theses ongoing, 14 theses concluded, of which 5 colateral with SB and IMX. M.E.R. since Nov 2008.
Total funding raised so far >18 MCHF (50% as main applicant; 30% outside CH; 20% industry).
Scientific output : >135 peer-reviewed publications, >120 conference papers, 40 invited presentations (8 keynotes), >70 granted proposals.
Fluent in 5 languages (Dutch, French, German ( Swiss-german), English, Spanish).
Kamiar AminianKamiar Aminian received the M.S. degree in electrical engineering in 1982, the Ph.D degree in biomedical engineering in 1989 and the Postgraduate degree on technical computing in 1993 from Ecole Polytechnique Fédérale de Lausanne (EPFL). He was assistant professor (1994-1996) with Sharif University of Technology (Tehran). He joint EPFL in 1996 where he is currently Professor of medical instrumentation and the director of the Laboratory of Movement Analysis and Measurement in the Institute of Bioengineering of EPFL. His research interests include methodologies for human movement monitoring and analysis in real world conditions mainly based on wearable technologies and inertial sensors with emphasis on gait, physical activity and sport. His research aims to perform outcome evaluation in orthopaedics, to improve motor function and intervention programs in aging and patients with movement disorders and pain, and to identify metrics of performance in sport science.
Kamiar Aminian is a member of the International Society of Posture and Gait Research, the Institute of Electrical and Electronics Engineers, the European Society of Movement Analysis in Adults and Children, the Prevention of fall Network Europe, the Intentional Society of Biomechanics and the President of the 3D analysis of the human movement group. He is author or co-author of more than 450 scientific papers published in reviewed journals and presented at international conferences and holds 10 patents related to medical devices.
Full CV
ORCID
Mathew Magimai DossTeaching & PhD PhD Students Karl El Hajal, Tilak Purohit Past EPFL PhD Students as codirector Ramya Rasipuram, Marzieh Razavi, Hannah Muckenhirn, Sandrine Tornay, Subrahmanya Pavankumar Dubagunta, Enno Hermann, Julian David Fritsch, Neha Tarigopula, Mostaani Zohreh, Eklavya Sarkar Courses Automatic speech processing EE-554 The goal of this course is to provide the students with the main formalisms, models and algorithms required for the implementation of advanced speech processing applicat
Stewart ColeProfessor Stewart Cole is an international authority in bacterial molecular-genetics and genomics. He has made outstanding contributions in several fields including: bacterial anaerobic electron transport; genome analysis of retroviruses and papillomaviruses; antibiotic resistance mechanisms; and the molecular microbiology of toxigenic clostridia. His studies on isoniazid and multidrug resistance in Mycobacterium tuberculosis, together with his pioneering work on the pathogenicity, evolution and genomics of the tubercle and leprosy bacilli, have made him an undisputed leader in the field of mycobacterial research. The findings of his research are of direct relevance to public health and disease-control in both the developing world and the industrialised nations. He has published over 250 scientific papers and review articles, and holds many patents.
Wulfram GerstnerWulfram Gerstner is Director of the Laboratory of Computational Neuroscience LCN at the EPFL. His research in computational neuroscience concentrates on models of spiking neurons and spike-timing dependent plasticity, on the problem of neuronal coding in single neurons and populations, as well as on the link between biologically plausible learning rules and behavioral manifestations of learning. He teaches courses for Physicists, Computer Scientists, Mathematicians, and Life Scientists at the EPFL. After studies of Physics in Tübingen and at the Ludwig-Maximilians-University Munich (Master 1989), Wulfram Gerstner spent a year as a visiting researcher in Berkeley. He received his PhD in theoretical physics from the Technical University Munich in 1993 with a thesis on associative memory and dynamics in networks of spiking neurons. After short postdoctoral stays at Brandeis University and the Technical University of Munich, he joined the EPFL in 1996 as assistant professor. Promoted to Associate Professor with tenure in February 2001, he is since August 2006 a full professor with double appointment in the School of Computer and Communication Sciences and the School of Life Sciences. Wulfram Gerstner has been invited speaker at numerous international conferences and workshops. He has served on the editorial board of the Journal of Neuroscience, Network: Computation in Neural Systems', Journal of Computational Neuroscience', and `Science'.
Georges WagnièresGeorges Wagnières received his diploma degree (MSc) in physics from the University of Lausanne, Switzerland, in 1986. He obtained his doctorate in science (PhD) in physics (Biomedical optics) from the Swiss Federal Institute of Technology at Lausanne (EPFL) in 1992 and did a postdoctoral work in the Wellman Laboratories of Photomedicine (Harvard Medical School), Boston, USA, from 1993 to 1994. He also obtained a Master degree in Management of Technology delivered by the Ecole des Hautes Etudes Commerciales (HEC) of Lausanne University and the EPFL in 2001. Georges Wagnières manages a research group active in the fields of: - Detection of early superficial cancers by fluorescence imaging. - Characterization of early superficial cancers by high magnification narrow band imaging. - In vivo and in vitro measurement of the vascular and tissular oxygen concentration by time-resolved luminescence spectroscopy and imaging. - Preclinical and clinical study of new photosensitizers for photodynamic therapy (PDT). - Treatment of neurodegenerative conditions (Alzheimer, Parkinson's diseases) by photobiomodulation. - Preclinical and clinical photodynamic therapy of inflammatory bowel diseases and atheroscerotic plaque. - Improvement of the selective vascular extravasation of chemotherapeutic agents by PDT. - Monitoring the light dosimetry during PDT by fluorescence spectroscopy and imaging. - Monitoring laser treatments of the retina by reflectance imaging. - Light dosimetry and tissue optical spectroscopy. - Radiometry. - Development of light delivery systems for biomedical applications. Georges Wagnières is also co-founder and was chairman of one spin-off companies: - Medlight SA, founded in July 1997, which develops, produces and commercializes light distributors for photodynamic therapy. Georges Wagnières has currently authored more than 235 papers (more than 150 in international journals with review board) and is inventor of 18 patents. He supervised 12 PhD students up to now, and currently teaches biomedical optics and photomedicine in master programs and doctoral schools. In addition, he gives the course entitled "Physique Générale I" to biology first year students registered to the Biology School of the Lausanne's University. MAIN PUBLICATIONS Please visit: https://www.epfl.ch/labs/lifmet/wagnieres/publications/